PIK3CA and neoplasm: Six (50%) of 12 patients were found to have one of three PIK3CA hotspot mutations in their tumour sample (Figure 1 + Table S3), however there was no difference in response to treatment between patients with PIK3CA wildtype (WT) and PIK3CA mutated tumours.